Form 8-K - Current report:
SEC Accession No. 0001493152-24-035317
Filing Date
2024-09-06
Accepted
2024-09-06 16:30:15
Documents
16
Period of Report
2024-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42982
2 ex4-1.htm EX-4.1 136721
3 ex10-1.htm EX-10.1 72454
4 ex99-1.htm EX-99.1 15966
  Complete submission text file 0001493152-24-035317.txt   496387

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pxmd-20240903.xsd EX-101.SCH 3018
6 XBRL LABEL FILE pxmd-20240903_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE pxmd-20240903_pre.xml EX-101.PRE 24167
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3693
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Filer) CIK: 0001811623 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41475 | Film No.: 241284890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)